Patent 8389676 was granted and assigned to Pacific Biosciences on March, 2013 by the United States Patent and Trademark Office.
Biotinylation peptides are provided which can be fused with other peptides or proteins of interest using recombinant DNA techniques to provide efficient methods for biotinylating the resulting fusion proteins in vivo or in vitro.